Mechanisms of Toxic Injury in the Peripheral Nervous System: NeuropathologiC Considerations

Toxicologic Pathology

Volumn 28, Issue 1, 2000, Pages 54-69

  Jortner, Bernard S ^a  

^a VIRGINIA MARYLAND REGIONAL COLLEGE OF VETERINARY MEDICINE   (United States)

Author keywords

2,5 hexanedione neurotoxicity; organophosphorous ester induced delayed neuropathy (OPIDN); p bromophenylacetylurea neurotoxicity; pyridoxine neurotoxicity; tellurium neurotoxicity; toxic axonopathy; toxic myelinopathy; Toxic neuronopathy

Indexed keywords

4 BROMOPHENYLACETYLUREA; ORGANOPHOSPHORUS COMPOUND; PYRIDOXINE; TELLURIUM; UNCLASSIFIED DRUG;

CLINICAL FEATURE; CONFERENCE PAPER; DRUG MECHANISM; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; NEUROPATHOLOGY; NEUROTOXICOLOGY; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL;

ANIMALIA; WALLERIA;

EID: 0033966072     PISSN: 01926233     EISSN: None     Source Type: Journal    
DOI: 10.1177/019262330002800108     Document Type: Article

References (113)

1. Abou-Donia MB (1981). Organophosphorous ester-induced delayed neurotoxicity. Ann Rev Pharmacol Toxicol 21: 511-548.
2. Abou-Donia MB (1993). The cytoskeleton as a target for organophosphorous ester-induced delayed neurotoxicity (OPIDN). Chem Biol Interact 87: 383-393.
3. Abou-Donia MB, Lapadula DM (1990). Mechanisms of organophosphorous ester-induced delayed neurotoxicity: Type I and type II. Ann Rev Pharmacol Toxicol 30: 405-440.
4. Albin RL, Albers JW, Greenberg HS, Townsend JB, Lynn RB, Burke JM Jr, Alessi AG (1987). Acute sensory neuropathy-neuronopathy from pyridoxine overdose. Neurology 37: 1729-1732.
5. Anthony DC (1997). Specificity of neurofilament swellings and axonal atrophy: Commentary on forum position paper. Neurotoxicology 18: 23-24.
6. Anthony DC, Boekelheide K., Graham DG (1983). The effect of 3,4-dimethyl substitution on the neurotoxicity of 2,5-hexanedione. I. Accelerated clinical neuropathy is accompanied by more proximal swellings. Toxicol Appl Pharmacol 71: 362-371.
7. Anthony DC, Giangaspero F., Graham DG (1983). The spatio-temporal pattern of the axonopathy associated with the neurotoxicity of 3,4-dimethyl-2,5-hexanedione in the rat. J Neuropathol Exp Neurol 42: 548-560.
8. Anthony DC, Montine TJ, Graham DG (1996). Toxic responses of the nervous system. In: Casarett and Doull's Toxicology. The Basic Science of Poisons, Klaassen CD (ed). McGraw-Hill, New York, pp 463-486.
9. Berger AR, Schaumburg HH, Schroeder C., Apfel S., Reynolds R. (1992). Dose response, coasting, and differential fiber vulnerability in human toxic neuropathy: A prospective study of pyridoxine neurotoxicity. Neurology 42: 1367-1370.
10. Bischoff A. (1967). The ultrastructure of tri-ortho-cresyl phosphate poisoning. I. Studies on myelin and axonal alterations in the sciatic nerve. Acta Neuropathol 9: 158-174.
11. Bischoff A. (1970). Ultrastructure of tri-ortho-cresyl phosphate poisoning in the chicken. II. Studies on spinal cord alterations. Acta Neuropathol 15: 142-155.
12. Blakemore WF, Cavanagh JB (1969). “Neuroaxonal dystrophy” occurring in an experimental “dying back” process in the rat. Brain 92: 789-804.
13. Bouldin TW, Cavanagh JB (1979). Organophosphorus neuropathy. I. A teased fiber study of the spatio-temporal spread of axonal degeneration. Am J Pathol 94: 241-252.
14. Bouldin TW, Cavanagh JB (1979). Organophosphorus neuropathy. II. A fine-structural study of the early stages of axonal degeneration. Am J Pathol 94: 253-270.
15. Bouldin TW, Earnhardt TS, Goines ND, Goodrum J. (1989). Temporal relationship of blood-nerve barrier breakdown to the metabolic and morphologic alterations of tellurium neuropathy. Neurotoxicology 10: 79-90.
16. Bouldin TW, Samsa G., Earnhardt TS, Krigman MR (1988). Schwann cell vulnerability to demyelination is associated with internodal length in tellurium neuropathy. J Neuropathol Exp Neurol 47: 41-47.
17. Cavanagh JB (1954). The toxic effects of tri-ortho-cresyl phosphate on the nervous system. An experimental study in hens. J Neurol Neurosurg Psychiatry 17: 163-172.
18. Chiu FC, Malchie R., He DK, Lehning EJ, LoPachin RM (1999). γ-Diketone neuropathy: III. Neurofilament subunit content. Toxicologist 38: 285-286.
19. Classen W., Gretener P., Rauch M., Weber E., Krinke GJ (1996). Susceptibility of various areas of the nervous system of hens to TOCP-induced delayed neuropathy. Neurotoxicology 17: 597-604.
20. Dalton K., Dalton Mjt (1987). Characteristics of pyridoxine overdose neuropathy syndrome. Acta Neurol Scand 76: 8-11.
21. DeCaprio AP (1985). Molecular mechanisms of diketone neurotoxicity. Chem Biol Interact 54: 257-270.
22. DeCaprio AP (1997). Axonal swellings vs. atrophy: What is the relevance to γ-diketone peripheral neuropathy? Commentary on forum position paper. Neurotoxicology 18: 25-28.
23. DeCaprio AP, Briggs RG, Jackowski SJ, Kim Jcs (1988). Comparative neurotoxicity and pyrrole-forming potential of 2,5-hexanedione and perdeuterio-2,5-hexanedione in the rat. Toxicol Appl Pharmacol 92: 75-85.
24. Driskell JA (1984). Vitamin B6. In: Handbook of Vitamins: Nutritional, Biochemical and Clinical Aspects, Machlin LJ (ed). Marcel Dekker, New York, pp 379-401.
25. Dyer KR, El-Fawal HA, Ehrich MF (1991). Comparison of organophosphate-induced delayed neuropathy between branches of the tibial nerve and the biventer cervicis nerve in chickens. Neurotoxicology 12: 687-695.
26. Dyer KR, Jortner BS, Shell LG, Ehrich M. (1992). Comparative dose-response studies of organophosphorus ester-induced delayed neuropathy in rats and hens administered mipafox. Neurotoxicology 13: 745-755.
27. Ehrich M. (1996). Neurotoxic esterase inhibition: Predictor of potential for organophosphorus-induced delayed neuropathy. In: Biomarkers for Agrochemicals and Toxic Substances, Blancato JN, Brown RN, Dary CC, Saleh MA (eds). American Chemical Society, Washington, DC, pp 79-93.
28. Ehrich M., Jortner BS (1999). Organophosphorus-induced delayed neuropathy (OPIDN). In: Handbook of Pesticide Toxicology, Krieger R (ed). Academic Press, San Diego, California (in press).
29. Ehrich M., Jortner BS, Padilla S. (1995). Comparison of the relative inhibition of acetylcholinesterase and neuropathy target esterase in rats and hens given cholinesterase inhibitors. Fundam Appl Toxicol 24: 94-101.
30. El-Fawal HA, Correll L., Gay L., Ehrich M. (1990). Protease activity in brain, nerve, and muscle of hens given neuropathy-inducing organophosphates and a calcium channel blocker. Toxicol Appl Pharmacol 103: 133-142.
31. El-Fawal HA, Jortner BS, Ehrich M. (1989). Effect of verapamil on organophosphorus-induced delayed neuropathy in hens. Toxicol Appl Pharmacol 97: 500-511.
32. El-Fawal HA, Jortner BS, Ehrich M. (1990). Modification of phenyl saligenin phosphate-induced delayed effects by calcium channel blockers: In vivo and in vitro electrophysiological assessment. Neurotoxicology 11: 573-592.
33. El-Fawal HA, Jortner BS, Ehrich M. (1990). Use of the biventer cervicis neve-muscle preparation to detect early changes following exposure to organophosphates inducing delayed neuropathy. Fundam Appl Toxicol 15: 108-120.
34. El-Fawal HA, Jortner BS, Eyre P., Ehrich M. (1988). The biventer cervicis nerve-muscle preparation of adult hens: Effects of phenyl saligenin phosphate administration. Neurotoxicology 9: 625-636.
35. Fox JH, Jortner BS, Lehning EJ, LoPachin RM, Perkins SK, Ward D. (1999). γ-Diketone neuropathy: 1. Qualitative neuropathic assessment. Toxicologist 48: 285.
36. Funk KA, Henderson JD, Liu CH, Higgins RJ, Wilson BW (1994). Neuropathology of organophosphate-induced delayed neuropathy (OPIDN) in young chicks. Arch Toxicol 68: 308-316.
37. Genter MB, Szakal-Quin G., Anderson CW, Anthony DC, Graham DG (1987). Evidence that pyrrole formation is a pathogenetic step in γ-diketone neuropathy. Toxicol Appl Pharmacol 87: 351-362.
38. Genter St. Clair MB, Anthony DC, Wikstrand CJ, Graham DG (1989). Neurofilament protein cross-linking in γ-diketone neuropathy: In vitro and in vivo studies using seaworm myxicola infundibulum. Neurotoxicology 10: 743-756.
39. Goodrum JF (1998). Role of organotellurium species in tellurium neuropathy. Neurochem Res 23: 1313-1319.
40. Goodrum JF, Earnhardt TS, Goines ND, Bouldin TW (1990). Lipid droplets in Schwann cells during tellurium neuropathy are derived from newly synthesized lipid. J Neurochem 55: 1928-1932.
41. Graham DG, Amarnath V., Valentine WM, Pyle SJ, Anthony DC (1995). Pathogenetic studies of hexane and carbon disulfide neurotoxicity. Crit Rev Toxicol 25: 91-112.
42. Graham DG, Genter St. Clair MB, Amarnath V., Anthony DG (1991). Molecular mechanisms of γ-diketone neuropathy. Adv Exp Med Biol 283: 427-431.
43. Graham DG, Szakal-Quin G., Priest JW, Anthony DC (1984). In vitro evidence that covalent cross-linking of neurofilaments occurs in γ-diketone neuropathy. Proc Natl Acad Sci USA 81: 4979-4982.
44. Gupta RP, Abdel-Rahman A., Wilmarth KW, Abou-Donia MB (1997). Alteration in neurofilament axonal transport in the sciatic nerve of the diisopropyl phosphorofluoridate (DFP)-treated hen. Biochem Pharmacol 53: 1799-1806.
45. Hammang JP, Duncan ID, Gilmore SA (1986). Degenerative changes in rat intraspinal Schwann cells following tellurium intoxication. Neuropathol Appl Neurobiol 12: 359-370.
46. Harry GJ, Goodrum JF, Bouldin TW, Wagner-Recio M., Toews AD, Morell P. (1989). Tellurium-induced neuropathy: Metabolic alterations associated with demyelination and remyelination in rat sciatic nerve. J Neurochem 52: 938-945.
47. Hoover DM, Carlton WW (1981). The subacute neurotoxicity of excess pyridoxine HCl and clioquinol (5-chloro-7-iodo-8-hydroxyquinoline) in beagle dogs. I. Clinical disease. Vet Pathol 18: 745-756.
48. Hoover DM, Carlton WW (1981). The subacute neurotoxicity of excess pyridoxine HCl and clioquinol (5-chloro-7-iodo-8-hydroxyquinoline) in beagle dogs. II. Pathology. Vet Pathol 18: 757-768.
49. Jakobsen J., Brimijoin S. (1981). Axonal transport of enzymes and labelled proteins in an experimental axonopathy induced by p-bromophenylacetylurea. Brain Res 229: 103-122.
50. Jakobsen J., Lambert EH, Carlson C., Brimijoin S. (1982). Clinical and electrophysiological characteristics of the experimental neuropathy caused by p-bromophenylacetylurea. Exp Neurol 75: 158-172.
51. Johnson MK (1975). The delayed neuropathy caused by some organophosphorus esters: Mechanism and challenge. CRC Crit Rev Toxicol 3: 289-316.
52. Johnson MK (1982). The target for initiation of delayed neurotoxicity by organophosphorus esters: Biochemical studies and toxicological application. In: Reviews in Biochemical Toxicology, Vol 4, Hodgson E, Bend J, Philpot RM (eds). Elsevier Biomedical, New York, pp 141-212.
53. Jortner BS (1984). Pathology of organophosphorus-induced delayed neurotoxicity. In: Proceedings of the 14th Conference on Environmental Toxicology, AFAMRL-TR-83-009 National Technical Information Service, Springfield, Virginia, pp 106-117.
54. Jortner BS, Dyer K., Musser J., Klein BG (1990). Acute toxic effects of pyridoxine excess on the trigeminal sensory system. Abstracts American Association of Neuropathology Meeting. June 1990, in San Francisco.
55. Jortner BS, Dyer K., Walton A., Ehrich M. (1997). Synaptophysin immunoreactive axonal swellings in p-bromophenylacetylurea-induced neuropathy. Neurotoxicology 18: 161-168.
56. Jortner BS, Ehrich M. (1987). Neuropathological effects of phenyl saligenin phosphate in chickens. Neurotoxicology 8: 303-314.
57. Jortner BS, Shell L., El-Fawal H., Ehrich M. (1989). Myelinated nerve fiber regeneration following organophosphorus ester-induced delayed neuropathy. Neurotoxicology 10: 717-726.
58. Krasavage WJ, O'Donoghue JL, DiVincenzo GD, Terhaar CJ (1980). The relative neurotoxicity of methyl-n-butyl ketone, n-hexane and their metabolites. Toxicol Appl Pharmacol 52: 433-441.
59. Krinke G., Naylor DC, Skorpil V. (1985). Pyridoxine megavitaminosis: An analysis of the early changes induced with massive doses of vitamin B6 in rat primary sensory neurons. J Neuropathol Exp Neurol 44: 117-129.
60. Krinke G., Schaumburg HH, Spencer PS, Suter J., Thomann P., Hess R. (1980). Pyridoxine megavitaminosis produces degeneration of peripheral sensory neurons (sensory neuronopathy) in the dog. Neurotoxicology 2: 13-24.
61. Krinke G., Ullmann L., Sachsee K., Hess R. (1979). Differential susceptibility of peripheral nerves of the hen to tri-ortho-cresyl phosphate and to trauma. Agents Actions 9: 227-231.
62. Krinke GJ, Fitzgerald RE (1988). The pattern of pyridoxine-induced lesion: Difference between the high and the low toxic level. Toxicology 49: 171-178.
63. Lampert P., Garro F., Pentschew A. (1970). Tellurium neuropathy. Acta Neuropathol 15: 308-317.
64. Lampert PW, Garrett RS (1971). Mechanism of demyelination in tellurium neuropathy. Electron microscopic observations. Lab Invest 25: 380-388.
65. Lapadula ES, Lapadula DM, Abou-Donia MB (1992). Biochemical changes in sciatic nerve of hens treated with tri-o-cresyl phosphate: Increased phosphorylation of cytoskeletal proteins. Neurochem Int 20: 247-255.
66. Lehning EJ, Dyer KS, Jortner BS, LoPachin RM (1995). Axonal atrophy is a specific component of 2,5-hexanedione peripheral neuropathy. Toxicol Appl Pharmacol 135: 58-66.
67. Lehning EJ, Jortner BS, Fox JH, Chiu FC, LoPachin RM (1999). γ-Diketone neuropathy: II. Morphometric analysis of axonal atrophy and swelling. Toxicologist 48: 285.
68. LoPachin RM, Lehning EJ (1997). The relevance of axonal swellings and atrophy to γ-diketone neurotoxicity: A forum position paper. Neurotoxicology 18: 7-22.
69. Lotti M. (1992). The pathogenesis of organophosphate polyneuropathy. CRC Crit Rev Toxicol 21: 465-488.
70. Lotti M., Caroldi S., Capodicasa E., Moretto A. (1991). Promotion of organophosphate-induced delayed polyneuropathy by phenylmethanesulfonyl fluoride. Toxicol Appl Pharmacol 108: 234-241.
71. Lotti M., Moretto A., Capodicasa E., Bertolazzi M., Peraica M., Scapellato ML (1993). Interactions between neuropathy target esterase and its inhibitors and the development of polyneuropathy. Toxicol Appl Pharmacol 122: 165-171.
72. Monaco S., Simonati A., Rizzuto N., Autilio-Gambetti L., Gambetti P. (1988). Hexacarbon axonopathy: The morphological expression of altered cytoskeletal translocation. In: Neurodegenerative Disorders: The Role Played by Endotoxins and Xenobiotics, Nappi G, Hornykiewicz O, Fariello RG, Agnoli A, Klawans H (eds). Raven Press, New York, pp 239-251.
73. Monaco S., Wongmongkolrit T., Shearson CM, Patton A., Schaetzle B., Autilio-Gambetti P., Sayre LM (1990). Giant axonopathy characterized by intermediate location and acceleration of neurofilament transport. Brain Res 519: 73-81.
74. Montpetit Vja, Clapin DF, Tryphonas L., Dancea S. (1988). Alteration of neuronal cytoskeletal organization in dorsal root ganglia associated with pyridoxine neurotoxicity. Acta Neuropathol 76: 71-81.
75. Morell P., Toews AD (1996). Schwann cells as targets for neurotoxicants. Neurotoxicology 17: 685-696.
76. Moretto A., Lotti M., Sabri MI, Spencer PS (1987). Progressive deficit of retrograde axonal transport is associated with the pathogenesis of di-n-butyl dichlorvos axonopathy. J Neurochem 49: 1515-1522.
77. Moretto G., Monaco S., Passarin MG, Benedetti MD, Rizzuto N. (1991). Cytoskeletal changes induced by 2,5-hexanedione on developing human neurons in vitro. Arch Toxicol 65: 409-413.
78. Nagata H., Brimijoin S. (1986). Axonal transport in the motor neurons of rats with neuropathy induced by p-bromophenylactylurea. Ann Neurol 19: 458-464.
79. Nagata H., Brimijoin S. (1986). Neurotoxicity of halogenated phenylacetylureas is linked to abnormal onset of rapid axonal transport. Brain Res 385: 136-142.
80. Ogawa Y., Komatsu T., Fujikake N., Fujii T., Tanaka J. (1993). Neurotoxic effects of 2,5-hexanedione on rapidly growing unmyelinated peripheral nerve axons of a rat fetus: Dose effect relationship. Environ Res 63: 287-294.
81. Ohnishi A., Ikeda M. (1980). Morphometric evaluation of primary sensory neurons in experimental p-bromophenylacetylurea intoxication. Acta Neuropathol 52: 111-118.
82. Oka B., Brimijoin S. (1992). Tubulomembranous lesions in p-bromophenylacetylurea neuropathy reflect local stasis of fast axonal transport: Evidence from electron microscopic autoradiography. Mayo Clin Proc 67: 341-348.
83. Oka N., Brimijoin S. (1990). Premature onset of fast axonal transport in bromophenylacetylurea neuropathy: An electrophoretic analysis of proteins exported into motor nerve. Brain Res 509: 107-110.
84. Olsson Y. (1984). Vascular permeability in the peripheral nervous system. In: Peripheral Neuropathy, Dyck PJ, Thomas PK, Lambert EH, Bunge R (eds). W. B. Saunders, Philadelphia, Pennsylvania, pp 579-597.
85. Padilla S., Veronesi B. (1985). The relationship between neurological damage and neurotoxic esterase inhibition in rats acutely exposed to tri-ortho-tolyl phosphate. Toxicol Appl Pharmacol 78: 78-87.
86. Pope CN, Padilla S. (1990). Potentiation of organophosphorus-induced delayed neurotoxicity by phenylmethylsulfonyl fluoride. J Toxicol Environ Health 31: 261-273.
87. Pope CN, Tanaka D., Padilla S. (1993). The role of neurotoxic esterase (NTE) in the prevention and potentiation of organophosphorus-induced delayed neurotoxicity (OPIDN). Chem Biol Interact 87: 395-406.
88. Prineas J. (1969). The pathogenesis of dying-back polyneuropathies, Part I. An ultrastructural study of experimental tri-ortho-cresyl phosphate intoxication in the cat. J Neuropathol Exp Neurol 28: 571-597.
89. Richardson RJ (1992). Interactions of organophosphorus compounds with neurotoxic esterase. In: Organophosphates: Chemistry, Fate, and Effects, Chambers JE, Levi PE (eds). Academic Press, San Diego, California, pp 299-323.
90. Rizzuto N., Terzian H., Galiazzo-Rizzuto S. (1977). Toxic polyneuropathies in Italy due to leather cement poisoning in shoe industries. J Neurol Sci 31: 343-354.
91. Rosenberg CK, Genter MB, Szakal-Quin G., Anthony DC, Graham DG (1987). Dl versus meso-3,4-dimethyl-2,5-hexanedione: A morphometric study of the proximodistal distribution of axonal swellings in the anterior root of the rat. Toxicol Appl Pharmacol 87: 363-373.
92. Rudman D., Williams PJ (1983). Megadose vitamins. Use and misuse. N Engl J Med 309: 488-489.
93. Sahenk Z., Mendell JR (1980). Zinc pyridinethione. In: Experimental and Clinical Neuropathology, Spencer PS, Schaumburg HH (eds). Williams and Wilkins, Baltimore, Maryland, pp 528-597.
94. Sayre LM, Autilio-Gambetti L., Gambetti P. (1985). Pathogenesis of experimental giant neurofilamentous axonopathies: A unified hypothesis based on chemical modification of neurofilaments. Brain Res Rev 10: 69-83.
95. Schaeppi U., Krinke G. (1982). Pyridoxine neuropathy: Correlation of functional tests and neuropathology in beagle dogs treated with large doses of vitamin B6. Agents Actions 12: 575-582.
96. Schaeppi U., Krinke G. (1985). Differential vulnerability of 3 rapidly conducting somatosensory pathways in the dog with vitamin B6 neuropathy. Agents Actions 16: 568-579.
97. Schaumburg H., Kaplan J., Windebank A., Vick N., Rasmus S., Pleasure D., Brown MJ (1983). Sensory neuropathy from pyridoxine abuse: A new megavitamin syndrome. N Engl J Med 309: 445-448.
98. Sladky JT, Xu Y., Brown MJ (1987). Transient ataxia after acute pyridoxine intoxication: Electrophysiologic and neuropathologic correlations. Neurology 37(suppl 1): 376.
99. Spencer PS, Couri D., Schaumburg HH (1980). n-Hexane and methyl n-butyl ketone. In: Experimental and Clinical Neuropathology, Spencer PS, Schaumburg HH (eds). Williams and Wilkins, Baltimore, Maryland, pp 456-475.
100. Spencer PS, Schaumburg HH (1977). Ultrastructural studies of the dying-back process. III. The evolution of experimental peripheral giant axonal degeneration. J Neuropathol Exp Neurol 36: 276-299.
101. Spencer PS, Schaumburg HH (1977). Ultrastructural studies of the dying-back process. IV. Differential vulnerability of PNS and CNS fibers in experimental central-peripheral distal axonopathies. J Neuropathol Exp Neurol 36: 300-320.
102. Spencer PS, Schaumburg HH, Sabri MI, Veronesi B. (1980). The enlarging view of hexacarbon neurotoxicity. Crit Rev Toxicol 7: 278-356.
103. Tanaka D., Bursian SJ, Lehning E. (1990). Selective and terminal degeneration in the chicken brainstem and cerebellum following exposure to bis(1-methylethyl)phosphorofluoridate (DFP). Brain Res 519: 200-208.
104. Tanaka DJ, Bursian SJ (1989). Degeneration patterns in the chicken central nervous system induced by ingestion of the organophosphorous delayed neurotoxin tri-ortho-tolyl phosphate. A silver impregnation study. Brain Res 484: 240-256.
105. Toews AD, Eckermann CE, Roberson MD, Lee SY, Morell P. (1991). Primary demyelination induced by exposure to tellurium alters mRNA levels for nerve growth factor receptor, SCIP, 2’,3'cyclic nucleotide 3’-phosphodiestersase, and myelin proteolipid protein in rat sciatic nerve. Mol Brain Res 11: 321-325.
106. Toews AD, Goodrum JF, Lee SY, Eckermann C., Morell P. (1991). Tellurium-induced alterations in 3-hydroxy-3-methylglutaryl-CoA reductase gene expression and enzyme activity: Differential effects in sciatic nerve and liver suggest tissue-specific regulation of cholesterol synthesis. J Neurochem 57: 1902-1906.
107. Toews AD, Lee SY, Popko B., Morell P. (1990). Tellurium-induced neuropathy: A model for reversible reductions in myelin protein gene expression. J Neurosci Res 26: 501-507.
108. US Environmental Protection Agency (1991). Pesticide Assessment Guidelines, Subdivision E. Hazard Evaluation: Human and Domestic Animals. Addendum 10: Neurotoxicity, Series 81, 82, and 83. US Environmental Protection Agency, National Technical Information Service, Springfield, Virginia.
109. Varghese RG, Bursian SJ, Tobias C., Tanaka D. Jr (1995). Organophosphorus-induced delayed neurotoxicity: A comparative study of the effects of tri-ortho-tolyl phosphate and triphenyl phosphite on the central nervous system of the Japanese quail. Neurotoxicology 16: 45-54.
110. Veronesi B., Padilla S., Blackmon K., Pope C. (1991). Murine susceptibility to organophosphorus-induced delayed neuropathy (OPIDN). Toxicol Appl Pharmacol 107: 311-324.
111. Windebank AJ, Low PA, Blexrud MD, Schmelzer JD, Schaumburg HH (1985). Pyridoxine neuropathy in rats: Specific degeneration of sensory axons. Neurology 35: 1617-1622.
112. Xu Y., Sladky JT, Brown MJ (1989). Dose-dependent expression of neuronopathy after experimental pyridoxine intoxication. Neurology 39: 1077-1083.
113. Zhu M., Spink DC, Yan B., Bauk S., DeCaprio AP (1994). Formation and structure of cross-linking and monomeric pyrrole autoxidation products in 2,5-hexanedione-treated amino acids, peptides and protein. Chem Res Toxicol 7: 551-558.